Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ/su vaccine subcutaneous versus intramuscular administration in adults aged 50 years and older
2012-005671-14Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by GSK. Started Aug 2013; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2012-005671-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005671-14.